Drug profile · INN
acyclovir
ZOVIRAX
acyclovir (ZOVIRAX) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — acyclovir
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 6
- Programs
- 10
- Data quality
- 0.89
Quick answer
acyclovir (ZOVIRAX) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Human herpesvirus 1 DNA polymerase inhibitor
Primary target: DNA polymerase catalytic subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11439585
Programmable pharmaceutical compositions for chrono drug release
granted -
US 11166906
Programmable pharmaceutical compositions for chrono drug release
granted -
US 11154494
Programmable pharmaceutical compositions for chrono drug release
granted -
US 10052467
Applicator for applying a fluid to a surface
granted -
US 9629805
Stabilization of moisture-sensitive drugs
granted -
US 9227044
Applicator for applying a fluid to a surface
granted
Frequently asked questions
What is acyclovir?
acyclovir (ZOVIRAX) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for acyclovir?
ZOVIRAX is a marketed brand name for acyclovir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acyclovir?
acyclovir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.